New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
N6-methylation is a modification in which a methyl group is added to the adenine base of a nucleotide. This modification is crucial for controlling important functions that are vital for gene expression, including mRNA splicing, stability, and translation. Due to its intricate participation in both...
Saved in:
Main Authors: | Mengran Li, Hu Tian, Yanshuang Zhuang, Zili Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533940/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01) -
N6-methyladenosine methylation regulators can serve as potential biomarkers for endometriosis related infertility
by: Yalun He, et al.
Published: (2024-12-01) -
Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets
by: Xuejin Lu, et al.
Published: (2025-01-01) -
Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
by: Minni Zhang, et al.
Published: (2025-01-01) -
Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
by: Biling Gan, et al.
Published: (2025-02-01)